About Custopharm
Custopharm is a Healthcare company based in Carlsbad (United States) founded in 2005, and was acquired by Hikma in September 2021. Employee benefits administration and insurance products are provided. Custopharm has completed 1 acquisition, including Aspire eCTD. Its chief executive, as recorded, is William Larkins. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation.
Company details
Custopharm was founded in 2005 and is based in Carlsbad, United States. Operations focus on the employee benefits and insurance sector, where various plans such as health savings accounts, cafeteria plans, and COBRA coverage are administered. Services include plan management, benefits consulting, and online tools. Insurance products encompass accident, cancer, disability, medical supplement, dental, vision, and life coverage. A benefits card is offered for access to FSA and HSA funds.
- Headquarters Carlsbad, United States
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website custopharm.com
- Social LinkedIn
- Acquired by Hikma (Sep 2021)
Funding Insights of Custopharm
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Custopharm with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2015 | Seed | – | – |
2 investors in total: 2 institutional.
Investors in Custopharm
Custopharm has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Hikma and Water Street.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Water Street is engaged in strategic investments in healthcare sectors. | 2005 | waterstreet.com | Chicago, United States | |
Generics and pharmaceutical products are manufactured by Hikma. | 1978 | hikma.com | Amman, Jordan |
Investor details for Custopharm
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Custopharm
1 people are tracked at Custopharm (1 in leadership).
| Name | Role | Group |
|---|---|---|
William Larkins | CEO | Leadership |
Complete people profiles for Custopharm
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Custopharm
Custopharm has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Aspire eCTD.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
eCTD software solutions are provided for pharmaceutical submissions. | aspireectd.com | Austin, United States | 2010 | Feb 2014 | •••• |
Complete acquisition details for Custopharm
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Custopharm
4 dated milestones of Custopharm across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Custopharm is founded.
- Acquisition Acquires Aspire eCTD.
- Funding First funding round.
- Exit Acquired by Hikma.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Custopharm (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Custopharm
Complete news archive for Custopharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Custopharm
Custopharm was founded in 2005 and raised its 1st funding round 10 years after it was founded.
Custopharm is headquartered in Carlsbad, United States. It is registered at Carlsbad, California, United States.
William Larkins is the CEO of Custopharm, as recorded in our data.
Custopharm was founded in 2005 and is based in Carlsbad, United States. Operations focus on the employee benefits and insurance sector, where various plans such as health savings accounts, cafeteria plans, and COBRA coverage are administered. Services include plan management, benefits consulting, and online tools. Insurance products encompass accident, cancer, disability, medical supplement, dental, vision, and life coverage. A benefits card is offered for access to FSA and HSA funds.
Custopharm has made 1 acquisition, including Aspire eCTD.
Custopharm has 2 investors. Key investors include Hikma, and Water Street.
Yes. Custopharm was acquired by Hikma in September 2021.